Barrington Research Maintains DENTSPLY $45 PT, Outperform - Dentsply Sirona (NASDAQ:XRAY)

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.

Barrington Research maintained its DENTSPLY (NASDAQ: XRAY) $45 price target and Outperform rating in a research report published today.In the report, Barrington Research states, "Management initiated fiscal 2012 guidance to a range of $2.22-2.30 per diluted share on adjusted basis. Currency exchange rates are expected to have a negative impact in 2012 on both top and bottom lines. The company cited innovation, a key driver of its results in 2011 and noted that there were several exciting new products in the pipeline."Shares of DENTSPLY closed today at $38.74, down 0.79% from Friday's market close.

27% profits every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!